Publisher： Bentham Science Publishers
E-ISSN： 2212-3873|14|3|182-186
ISSN： 1871-5303
Source： Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.14, Iss.3, 2014-09, pp. : 182-186
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
A critical assessment of oxaprozin clinical profile in rheumatic diseases
By Kean Walter F. Kean Robert Buchanan W. Watson
Inflammopharmacology, Vol. 10, Iss. 3, 2002-08 ,pp. :
Access to resources
Recommend
A Risk-Benefit Assessment of Intra-Articular Corticosteroids in Rheumatic Disorders
Drug Safety, Vol. 21, Iss. 5, 1999-11 ,pp. :
Chemokines in Rheumatic Diseases
Current Drug Targets, Vol. 7, Iss. 1, 2006-01 ,pp. :